Cargando…
Cervical cancer screening programmes and policies in 18 European countries
A questionnaire survey was conducted by the Epidemiology Working Group of the European Cervical Cancer Screening Network, and the International Agency for Research on Cancer, IARC, between August and December 2003 in 35 centres in 20 European countries with reliable cervical cancer incidence and/or...
Autores principales: | , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2004
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2409887/ https://www.ncbi.nlm.nih.gov/pubmed/15280916 http://dx.doi.org/10.1038/sj.bjc.6602069 |
_version_ | 1782155890252578816 |
---|---|
author | Anttila, A Ronco, G Clifford, G Bray, F Hakama, M Arbyn, M Weiderpass, E |
author_facet | Anttila, A Ronco, G Clifford, G Bray, F Hakama, M Arbyn, M Weiderpass, E |
author_sort | Anttila, A |
collection | PubMed |
description | A questionnaire survey was conducted by the Epidemiology Working Group of the European Cervical Cancer Screening Network, and the International Agency for Research on Cancer, IARC, between August and December 2003 in 35 centres in 20 European countries with reliable cervical cancer incidence and/or mortality data in databanks held at IARC and WHO. The questionnaire was completed by 28 centres from 20 countries. The final tables included information on 25 centres from 18 countries. Six countries had started screening in the 1960s, whereas 10 countries or regions had started at least a pilot programme by 2003. There were six invitational and nine partially invitational programmes, the rest employing opportunistic screening only. Recommended lifetime number of smears varied from seven to more than 50. Coverage of smear test within the recommended screening interval (usually 3 or 5 years) was above 80% in three countries. Screening registration took place in 13 programmes. Eight programmes reported the rates of screen-detected cervical cancers and precursor lesions. There was wide variation in the CIN3 detection rates. International guidelines and quality assurance protocols are useful for monitoring and evaluating screening programmes systematically. Our survey indicated that the recommendations as currently given are met in only few European countries. Health authorities need to consider stronger measures and incentives than those laid out in the current set of recommendations. |
format | Text |
id | pubmed-2409887 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2004 |
publisher | Nature Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-24098872009-09-10 Cervical cancer screening programmes and policies in 18 European countries Anttila, A Ronco, G Clifford, G Bray, F Hakama, M Arbyn, M Weiderpass, E Br J Cancer Epidemiology A questionnaire survey was conducted by the Epidemiology Working Group of the European Cervical Cancer Screening Network, and the International Agency for Research on Cancer, IARC, between August and December 2003 in 35 centres in 20 European countries with reliable cervical cancer incidence and/or mortality data in databanks held at IARC and WHO. The questionnaire was completed by 28 centres from 20 countries. The final tables included information on 25 centres from 18 countries. Six countries had started screening in the 1960s, whereas 10 countries or regions had started at least a pilot programme by 2003. There were six invitational and nine partially invitational programmes, the rest employing opportunistic screening only. Recommended lifetime number of smears varied from seven to more than 50. Coverage of smear test within the recommended screening interval (usually 3 or 5 years) was above 80% in three countries. Screening registration took place in 13 programmes. Eight programmes reported the rates of screen-detected cervical cancers and precursor lesions. There was wide variation in the CIN3 detection rates. International guidelines and quality assurance protocols are useful for monitoring and evaluating screening programmes systematically. Our survey indicated that the recommendations as currently given are met in only few European countries. Health authorities need to consider stronger measures and incentives than those laid out in the current set of recommendations. Nature Publishing Group 2004-08-31 2004-07-27 /pmc/articles/PMC2409887/ /pubmed/15280916 http://dx.doi.org/10.1038/sj.bjc.6602069 Text en Copyright © 2004 Cancer Research UK https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material.If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Epidemiology Anttila, A Ronco, G Clifford, G Bray, F Hakama, M Arbyn, M Weiderpass, E Cervical cancer screening programmes and policies in 18 European countries |
title | Cervical cancer screening programmes and policies in 18 European countries |
title_full | Cervical cancer screening programmes and policies in 18 European countries |
title_fullStr | Cervical cancer screening programmes and policies in 18 European countries |
title_full_unstemmed | Cervical cancer screening programmes and policies in 18 European countries |
title_short | Cervical cancer screening programmes and policies in 18 European countries |
title_sort | cervical cancer screening programmes and policies in 18 european countries |
topic | Epidemiology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2409887/ https://www.ncbi.nlm.nih.gov/pubmed/15280916 http://dx.doi.org/10.1038/sj.bjc.6602069 |
work_keys_str_mv | AT anttilaa cervicalcancerscreeningprogrammesandpoliciesin18europeancountries AT roncog cervicalcancerscreeningprogrammesandpoliciesin18europeancountries AT cliffordg cervicalcancerscreeningprogrammesandpoliciesin18europeancountries AT brayf cervicalcancerscreeningprogrammesandpoliciesin18europeancountries AT hakamam cervicalcancerscreeningprogrammesandpoliciesin18europeancountries AT arbynm cervicalcancerscreeningprogrammesandpoliciesin18europeancountries AT weiderpasse cervicalcancerscreeningprogrammesandpoliciesin18europeancountries |